MayaHasan(Hasan)MaloneyMD

Retinal Disease

Physician

Dr. Maloney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Mayo Clinic College of Medicine and ScienceFellowship, Medical Retina, 2015 - 2016
Mayo Clinic College of Medicine and Science (Rochester)Residency, Ophthalmology, 2012 - 2015
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2011 - 2012
Yale School of MedicineClass of 2011

PubMed

Autoimmune Retinopathy in a Patient with Stiff-Person Syndrome: A Case Report.
Shah, R., Maloney, M., Gilbert, A., Patel, A., Vora, R.> ;Retinal Cases & Brief Reports. 2023 Dec 19
33 citations
Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice.
Maya Maloney, Stephanie Payne, Jeph Herrin, Lindsey R. Sangaralingham, Nilay Shah, Andrew J. Barkmeier> ;Ophthalmology. 2021 Mar 1
30 citations
Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice.
Maya Maloney, Stephanie R. Schilz, Jeph Herrin, Lindsey R. Sangaralingham, Nilay Shah, Andrew J. Barkmeier> ;Ophthalmology. 2019 Jul 1
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.
Cosgrove, B.D., King, B.M., Hasan, M.A., Alexopoulos, L.G., Farazi, P.A., Hendriks, B.S., Griffith, L.G., Sorger, P.K., Tidor, B., Xu, J.J., Lauffenburger, D.A.> ;Toxicol Appl Pharmacol. 2009-06-15
Join now to see all